Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma: final analysis of a randomized phase III dermatologic cooperative oncology group trial - Mohr, Peter; Enk, Alexander (Journal of clinical oncology, 2015)
Gesehen am 28.07.2016